[New antithrombotic agents. Towards a new therapeutic plan].
Fiessinger
Jean-Noël
JN
Service de médecine vasculaire, Hôpital Européen Georges Pompidou, 75908 Paris. jean-noel.fiessinger@egp.ap-hop-paris.fr
D000925:Anticoagulants / Q000627:therapeutic use*; D001384:Azetidines / Q000627:therapeutic use*; D001596:Benzylamines; D002986:Clinical Trials as Topic; D000077425:Fondaparinux; D006801:Humans; D019637:Orthopedic Procedures / Q000009:adverse effects; D011134:Polysaccharides / Q000627:therapeutic use*; D020246:Venous Thrombosis / Q000517:prevention & control*
D000925:Anticoagulants; D001384:Azetidines; D001596:Benzylamines; D011134:Polysaccharides; C426686:ximelagatran; D000077425:Fondaparinux